Subscribe

Nordhealth AS (NORDH.OL)

NOK22.20 +0.00 (+0.00%)
FI OSL Healthcare Medical - Healthcare Information Services
Address Hasleveien 28A 571
Helsinki, FI
CEO Charles William MacBain
Website nordhealth.com
IPO 2021-06-04
ISIN NO0011002651

Explore sections of this company profile

Description

Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Vetserve, Sanimalis, Vetvision, and Vetera names. The company’s products comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation. In addition, it offers services related to implementation of the SaaS systems, such as consultancy services, education, and data conversion. Further, the company provides nordhealth.fi, a consumer booking portal. Nordhealth AS was founded in 2001 and is based in Oslo, Norway.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
NOK22.20 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
16.6K
Beta
0.35
Float Shares
74.42M
Free Float %
94.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% -2.14% +13.22% -8.67% -14.38% -23.89% -27.13% +30.48% -29.74% -29.74% -29.74%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
22.20
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
7.38
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +10.1% Q1'26: +7.9% (vs Q1'25)
  • ✗
    EPS growth Medical - Healthcare Information Services: +43.1%
    -64.8% Q1'26: -89.9% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    -14.4% Q1'26: +2.6% (vs Q1'25)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    -25.0% Q1'26: -36.2% (vs Q1'25)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    -26.8% Q1'26: -44.9% (vs Q1'25)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +1.5% Q1'26: -0.3% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.33) × ERP
WACC = 100% × Ke + 0% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 22.20
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
20.30M
est: 20.10M (+1.0%)
31.05M
est: 30.86M (+0.6%)
36.83M
est: 36.87M (-0.1%)
45.68M
est: 45.44M (+0.5%)
50.29M
est: 52.00M (-3.3%)
51.91M
51.91M – 51.91M
-0.2% YoY
61.02M
61.02M – 61.02M
+17.5% YoY
71.04M
71.04M – 71.04M
+16.4% YoY
EBITDA
-369.0K
est: 651.9K (-156.6%)
-5.41M
est: 1.00M (-640.4%)
-659.0K
est: 1.20M (-155.1%)
4.21M
est: 3.96M (+6.4%)
-1.41M
est: 4.53M (-131.2%)
4.53M
4.53M – 4.53M
-0.2% YoY
5.32M
5.32M – 5.32M
+17.5% YoY
6.19M
6.19M – 6.19M
+16.4% YoY
EBIT
-4.61M
est: -3.85M (-19.6%)
-14.11M
est: -5.91M (-138.6%)
-10.80M
est: -7.06M (-52.8%)
-6.60M
est: -5.90M (-11.8%)
-12.57M
est: -6.75M (-86.2%)
-6.74M
-6.74M – -6.74M
+0.2% YoY
-7.92M
-7.92M – -7.92M
-17.5% YoY
-9.22M
-9.22M – -9.22M
-16.4% YoY
Net Income
-4.73M
est: 1.59M (-397.8%)
-14.26M
est: -7.96M (-79.3%)
-11.13M
est: -2.39M (-365.1%)
-7.67M
est: -1.60M (-378.7%)
-12.54M
est: -3.21M (-291.0%)
-2.19M
-2.19M – -2.19M
+31.7% YoY
3.65M
3.65M – 3.65M
+266.7% YoY
10.23M
10.23M – 10.23M
+180.0% YoY
SGA
3.94M
est: 2.20M (+79.0%)
3.71M
est: 3.38M (+9.8%)
3.10M
est: 4.03M (-23.1%)
3.13M
est: 6.91M (-54.7%)
14.81M
est: 7.91M (+87.2%)
7.90M
7.90M – 7.90M
-0.2% YoY
9.28M
9.28M – 9.28M
+17.5% YoY
10.81M
10.81M – 10.81M
+16.4% YoY
EPS
-0.06
est: 0.02 (-394.0%)
-0.18
est: -0.10 (-78.8%)
-0.14
est: -0.03 (-362.3%)
-0.10
est: -0.02 (-385.7%)
-0.16
est: -0.04 (-300.0%)
-0.03
-0.03 – -0.03
+31.7% YoY
0.05
0.05 – 0.05
+266.7% YoY
0.13
0.13 – 0.13
+180.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-19 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-18 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-15 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-13 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-4.30M
OE per share TTM
-0.05
Owner's Yield
-0.20%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-25.6K
Shares Outstanding
78.81M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Alexander Cram Group Chief Financial Officer — —
Charles MacBain Group Chief Executive Officer — male
James Stanier Chief Technology Officer — —
Janne Huttunen Chief Innovation Officer of Veterinary & Board Member — male
Karan Wallia Chief Executive Officer of the Therapy Business Unit — male
Valter Pasanen Chief Executive Officer of Veterinary Business Unit — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services